Coagulation and Innate Plasma Proteins Notes

Coagulation and Immune Benefits of Blood Clots

  • Primary purpose of a blood clot: stop the bleeding and maintain hemostasis.

  • Immune benefits of coagulation:

    • Immobilizes microorganisms to prevent entry into blood and lymph, reducing systemic spread.
    • If microbes enter the bloodstream, they can disseminate rapidly and potentially cause sepsis.
    • Coagulation helps reduce loss of blood and fluid at the site of injury.

  • Beyond clot formation, the coagulation system releases mediators that contribute to antimicrobial defense, including:

    • Wound healing to reestablish the epithelial barrier.
    • Inflammatory mediators that participate in the immune response.

  • The kinin system as part of plasma protein cascades:

    • An enzymatic cascade with multiple regulatory steps (casually described as a cascade with checkpoints) to prevent excessive activation.
    • End result includes vasodilation and enhanced delivery of immune components to the infection site.

  • Role of kinins and vasodilation:

    • Kinins promote vasodilation, increasing the supply of soluble and cellular materials to the infected area, supporting both innate and cellular immune responses.

  • Protease inhibitors in plasma:

    • Plasma contains protease inhibitors that block proteases secreted by pathogens or produced during immune responses.
    • Proteases are enzymes that cleave proteins; many pathogens secrete proteases to invade tissues and access nutrients.
    • Host protease inhibitors protect tissues (e.g., collagen matrix) from pathogen proteases and from protease activity during inflammation.
    • Approximately 10%10\% of serum proteins are protease inhibitors.

  • Liver-derived protease inhibitors and the rationale for them:

    • Many protease inhibitors are glycoproteins.
    • They provide protection against pathogen-derived proteases and help regulate proteolytic cascades during inflammation.

  • Alpha-2 macroglobulin (A2M): a key protease inhibitor with a bait mechanism

    • A2M is produced by the liver and released into the blood.
    • The “bait” strategy: A2M presents a peptide sequence that resembles a typical protease substrate.
    • When a protease attacks the bait, a thioester bond within A2M reacts to trap the protease, forming a covalent complex.
    • The baited protease is effectively inactivated and shrouded, preventing it from damaging host tissues.
    • Mechanism can be summarized as:
    • bait peptide→protease recognition→thioester trap→protease inactivation.\text{bait peptide} \rightarrow \text{protease recognition} \rightarrow \text{thioester trap} \rightarrow \text{protease inactivation}.

  • Defensins: small antimicrobial peptides in the plasma and mucosal secretions

    • Defensins are short amphipathic proteins with two distinct ends that are typically hydrophobic and hydrophilic, enabling interaction with and disruption of microbial membranes.
    • Two main classes:
    • Alpha defensins: secreted by Paneth cells in the small intestine (base of crypts) into the gut lumen; also produced by neutrophils within phagosomes.
    • Beta defensins: secreted by epithelial cells on mucosal surfaces and in skin; abundant in skin folds (e.g., axillary areas) and respiratory and urogenital tracts.
    • Activation and localization:
    • Defensins are secreted in inactive forms and require activation by local conditions (e.g., low pH in tears or gut lumen) or processing within neutrophil phagosomes.
    • Mechanism of action in membranes:
    • Defensins are amphipathic, allowing them to insert into lipid bilayers, disrupt the membrane, and create pores or otherwise damage the microbial membrane.
    • Biological relevance and sites:
    • Gut lumen: Paneth cells secrete defensins; defensins also secreted by neutrophils into the phagosome.
    • Skin and mucosa: Beta defensins secreted by epithelial cells in the skin, respiratory tract, and urogenital tract.
    • Practical notes on defensin subclasses:
    • There are many subclasses (e.g., alpha and beta defensins with further subtypes). While memorizing every subclass is not required for many courses, it is useful to recognize that different defensins have varying structures and specific tissue distributions.
    • Clinical and educational context:
    • In some graduate immunology programs you may encounter memorization of individual defensin subtypes; for many introductory courses, focusing on the two main classes and their general sites of secretion and action is sufficient.

  • Pentraxins: pentameric innate immune opsonins

    • Structure: pentraxins are proteins composed of five subunits that polymerize into a cyclic multimeric pentagram-like ring.
    • Functions:
    • Bind to surfaces of various pathogens and act as opsonins, tagging pathogens for destruction.
    • Serve as bridging molecules that connect pathogens to human cell receptors on phagocytes, promoting phagocytosis.
    • Cellular receptors and mechanisms:
    • Phagocytes (dendritic cells, neutrophils, macrophages) recognize pentraxins via surface receptors such as CD89 (CD89 is a receptor involved in recognizing pentraxins in addition to other ligands).
    • Pentraxins enhance phagocytosis by engaging these receptors, similar to antibodies, but are part of the innate immune system and lack antigen-specificity.
    • Short vs. long pentraxins:
    • Short pentraxins (e.g., SAP, C-reactive protein [CRP], PTX3 is often categorized as a long pentraxin in some contexts) are primarily produced by the liver.
    • Long pentraxins can be secreted by other cell types, including monocytes, macrophages, dendritic cells, endothelial cells, and epithelial cells.
    • Roles and sources:
    • Short pentraxins target bacteria, viruses, fungi, and parasites.
    • Long pentraxins are secreted by a broader range of cells and can participate in tagging pathogens in the bloodstream and tissues.
    • Monocytes (in their circulating, immature state) have some innate functions and can secrete long pentraxins;
      this helps tag pathogens that may reach the liver, spleen, or other organs for macrophages to clear later.
    • Receptors and shared pathways:
    • Pentraxins and antibodies both engage receptors on phagocytes to promote phagocytosis, highlighting a functional overlap between innate and adaptive immunity.

  • Summary: integrated roles of plasma proteins in innate defense

    • Coagulation and its mediators contribute to antimicrobial defense beyond hemostasis, including immobilization of pathogens and recruitment of immune elements.
    • The kinin system provides regulated vasodilation to increase immune cell and factor delivery to infection sites.
    • Protease inhibitors (notably alpha-2 macroglobulin) protect host tissues by neutralizing proteases from pathogens and during inflammatory cascades, using a unique bait-and-trap mechanism involving a thioester bond.
    • Defensins (alpha and beta) represent key amphipathic antimicrobial peptides that disrupt microbial membranes, with distinct tissue distributions and activation requirements.
    • Pentraxins act as innate immune opsonins and bridging molecules that enhance phagocytosis by engaging phagocyte receptors, overlapping with antibody-mediated pathways but without antigen specificity.

  • Connections to foundational principles and real-world relevance

    • Innate immunity provides rapid, non-specific defense that primes and accelerates adaptive responses; many of the components described (defensins, pentraxins, protease inhibitors) are classic examples of innate effector molecules.
    • Understanding how protease activity is regulated highlights the balance between host defense and tissue protection; dysregulation can contribute to inflammatory pathology.
    • The concept of receptor sharing between pentraxins and antibodies emphasizes continuity between innate and adaptive strategies and explains why innate components can enhance phagocytosis even before antigen-specific responses mature.
    • The location-specific expression of defensins (gut Paneth cells, skin, mucosal epithelia) underscores how barrier tissues are actively fortified by specialized antimicrobial peptides.

  • Mathematical and molecular notes (LaTeX-formatted)

    • Protease inhibitor prevalence in serum: 10%10\% of serum proteins are protease inhibitors.
    • Alpha-2 macroglobulin mechanism (conceptual equation):
    • extProtease+extA2M(bait)→Protease-A2M complex (trapped via thioester)ext{Protease} + ext{A2M (bait)} \rightarrow \text{Protease-A2M complex (trapped via thioester)}
    • Thioester bond in trap mechanism can be represented as a generic covalent捕: R−C(=O)−S−R′ (thioester)R-C(=O)-S-R'\text{ (thioester)} used to trap proteases after bait cleavage.

  • Practical implications for exams and applications

    • Be able to explain at a high level why clotting is not only hemostatic but also immunoprotective.
    • Describe the role of the kinin system and why regulated cascades matter in preventing collateral tissue damage.
    • Recognize that protease inhibitors are critical to defend against pathogen proteases and to temper inflammatory proteolysis; know the approximate proportion of protease inhibitors in serum.
    • Distinguish alpha versus beta defensins in terms of source, location, and primary sites of activity; understand the amphipathic mechanism of action and activation requirements.
    • Explain the function of pentraxins as innate analogs to antibodies in promoting phagocytosis and their receptors on phagocytes (e.g., CD89).
    • Appreciate the interconnectedness of innate and adaptive immunity through shared receptors and effector pathways.

  • Note on terminology and scope

    • The transcript covers a broad overview suitable for an introductory immunology course; some details (e.g., full defensin subclass lists) are more advanced and may be encountered in graduate study or specialized coursework.

  • End of chapter two content review

    • The innate plasma protein systems (coagulation-associated mediators, kinins, protease inhibitors, defensins, and pentraxins) provide not only defense at barrier sites but also rapid coordination of immune effector functions, setting the stage for subsequent chapters on specific immune pathways and responses.